As the CXCR4 receptor for CXCL12 is expressed on both the tumor cells and EPCs [123,124], CAF-produced CXCL12 stimulates tumor growth and neoangiogenesis via acting CXCR4 expressed on these cells. The gene discussed is CXCL12; the disease is neoplasm.